Résumé

Kanav Jain

AI product leader, engineer, and researcher. Advisory and fractional product leadership for healthcare and AI ventures. I partner with technical founders to take complex clinical systems through review, unblock patient adoption, and build products that last.

  • NextConsensus founded
  • Ambit built
  • Refract built
  • Stims developed
  • Fast Harm, Slow Repair designed (a recovery-evaluation scaffold)
Download PDF
  • 14 years in healthcare technology Epic, Doximity, Transcarent, CancerCompass
  • 300K+ Doximity Dialer calls per average workday Doximity Investor Relations, Feb 2026
  • 250+ hospitals and health systems on Dialer The same Doximity Investor Relations release

Independent Product Builder

NextConsensus, Ambit, Refract

2024–present

In every role, the hard part has been getting a working prototype approved, fitted into how people work, and owned by someone. Built three early products myself: NextConsensus (dated forecasts of guideline, label, and coverage decisions), Ambit (agent capability and authorization mapping, MIT-licensed), and Refract (the change-tracking engine beneath NextConsensus, AGPL-licensed). Fast Harm is a draft test of how far an AI error travels before a correction catches it, and Whether turns macro conditions into a weekly operating call.

  • Founded and lead NextConsensus, which registers the probability that a named body — the FDA, NICE, a guideline committee — takes a defined action by a set date. Each estimate is built from that body’s own review record, frozen before the outcome is known, and scored against public resolution rules; none has resolved yet. Built for market access, health economics and outcomes research (HEOR), regulatory, and BD teams working against dates that do not move.
  • Built Stims as a standalone engineering product: a browser-native MilkDrop-style visualizer with 1,787 presets, direct .milk compilation, live editing, WebGL2/WebGPU rendering, in-browser recording in beta, and a harness that checks fidelity against projectM. Four of its parts ship as standalone npm packages.
  • Built Refract (AGPL-3.0), an open-source engine that replays a source’s revision history into byte-reproducible change events: when a claim first appeared, whether its hedging strengthened or weakened, whether it survived reversion, what editors disputed. A scheduled bot runs it against a live article; the published test set is 15,926 events.
Open-source engines
Engine License Layer What it does Proof
Refract AGPL-3.0 Trace Replays a source’s revision history into byte-reproducible change events 15,926 events in a fixed, hash-pinned corpus; a separate bot observes ongoing changes
Ambit MIT Control Models an agent’s tool access and the authority over it Tests for permission expiry when a capability stops passing its check

Co-Founder and CEO

Andwise

2022–2024

Co-founded and led a physician financial-wellness company across product, funding, and go-to-market. The product helped doctors with contracts, debt, and the move from training to practice.

  • Built the Contract Analyzer: automated clause-level analysis flagging risky terms in physician contracts. A JD wrote the legal content, and the product stopped at analysis without giving legal advice.
  • Raised $240K in initial funding and grew to 1,200+ physician users and a 700-member community, then wound the company down in 2024, with funding and engagement both short, rather than rebuild it around an employer or a financial advisor as the paying customer.
  • Convened a physician medical advisory board to establish the clinical review protocols every contract analysis had to clear.

Director of Product, Care Experiences

Transcarent

2021–2022

Early product hire. Led Surgery, Everyday Urgent Care, Behavioral Health, and Oncology Care from the first activated member through 200+ FTEs — the period in which the company reached a $1.6B implied valuation.

  • Led the Cancer & Decision Support pod, which shipped CancerCare v1: a triage tool, built on Healthwise content, that inferred the care pathway for adults and children from reported symptoms, and an in-app second-opinion flow that handed off automatically to a nurse line.
  • Designed automated routing rules tied to clinical roles across four specialty-care programs. The system assigned each case to the right clinician, while nurses and navigators worked from a shared record during live care coordination.
  • Managed two product managers across four specialty-care programs.

Director of Digital Products & Strategy

CancerCompass / CTCA

2019–2021

Directed digital product for CancerCompass, a Cancer Treatment Centers of America (CTCA) venture: an oncology information and navigation platform serving 30 million annual visitors. City of Hope acquired CTCA in 2022; CancerCompass had wound down before the deal.

  • First product and technical hire for a pre-CEO, pre-revenue corporate venture, through its growth from 2 to 25 FTEs.
  • Led a cross-functional R&D team of 14 onshore and offshore across three products: the health information site (30 million annual visitors), a hospital digital-marketing platform, and a patient-engagement web app.
  • Reduced bounce rate by 25%, increased chat conversions by 267%, and raised time on page by 40% through iterative multivariate testing.

Head of Mobile Products & Growth

Doximity — Hiring & Hospital Marketing; Search & User Growth; Mobile Apps

2013–2017

Joined as a Product Manager, was promoted in July 2016, and left running user growth and the mobile portfolio. Nine product launches across four years, teams of three to ten, and founding product lead for Doximity Dialer.

  • As founding product lead for Doximity Dialer, proved over a weekend that outbound calls could carry an unverified caller ID, and launched on that route deliberately: Doximity’s physician identity verification stood behind the number, with no clinical decision riding on the call. Partnered with legal and hospital IT to clear EHR integration, including Epic Haiku. Dialer now carries more than 300,000 calls on an average workday across 250+ hospitals and health systems.
  • Grew Talent Finder revenue 60% YoY to $5M across 1,000+ physician recruiters and 400+ paying clients, reaching 1.8M monthly impressions. The team: four web engineers, a UX designer, a data scientist, and a QA engineer. Built the enterprise marketing platform used by 6 of the top 10 U.S. research hospitals to identify likely referrers for their specialty physicians.
  • Ran a national physician compensation survey: 35,000+ unique, ID-verified respondents in one year. Directed the data-science team that turned it into a salary model, trained on 25+ public and private data sources, that predicted pay by U.S. county and medical specialty.

Technical Services Engineer

Epic

2012–2013

Led post-install success for two outpatient software clients and six patient web-portal clients through root-cause analysis, re-implementation, and custom Caché development where the base product couldn’t reach. Co-led Epic’s PQRS subject-matter group.

  • Converted a 477-bed regional health organization from cancellation risk to reference account by resolving 95% of the outpatient issue list through root-cause analysis, re-implementation, and custom plug-in development.
  • Took the MyChart patient portal (web and mobile) and EpicCare Link live at a research hospital in a 134-year-old health system.
  • Co-led Epic’s five-person PQRS subject-matter group, covering CMS’s Physician Quality Reporting System, and created its escalation path for regulatory issues and critical software bugs, from discovery and triage through customer notification.
Earlier roles: research, venture fellowships, and clinical quality (2009–2019)

Venture Fellow

Rough Draft Ventures (now GC Venture Fellows)

2018–2019

Evaluated seed-stage healthcare and deep-tech teams for General Catalyst’s student-founder program.

MBA Associate

Red Sea Ventures

Dec 2017–Jan 2019

Sourced and diligenced seed and Series A companies at a three-person, $50M thesis-driven fund. Met 100+ founders, wrote memos, presented recommendations to partners, and developed the firm’s investment philosophy on the consumerization of healthcare.

Fellow

InSITE

2018–2019

Graduate-student fellowship in the New York cohort, placing fellows as consultants to early- and growth-stage startups.

  • Selected to run a full investment analysis of Phosphorus, a clinical-genomics company offering hereditary-risk tests: business-model teardown, FDA regulatory risk, and comparable-company analysis.

Clinical Quality Analyst (pro bono)

Emory University Hospital

Sep–Nov 2013

Supported an initiative to reduce surgical site infections through process development and data analysis.

Research Intern

Memorial Sloan Kettering Cancer Center

2011

Research internship on cancer-derived exosomes and premalignant change linking lung cancer and COPD.

  • Established cross-department sample-collection protocols bridging thoracic surgery and research labs.

Research Assistant

Georgia Tech / NASA

2009–2012

Studied the thermodynamics of small regulatory RNAs (sRNAs), their pairing with target mRNAs, and the role of the Hfq protein.

  • First author on a chapter in the ACS Symposium Series (Vol. 1082, 2011) on the thermodynamics of sRNA–mRNA interactions and the role of Hfq. Presented at FASEB, BMES, and the ACC Meeting of the Minds — one of eight students selected institute-wide.
  • Ran thermal denaturation (melting) experiments measuring how Hfq changes the stability of sRNAs and their pairing with target mRNAs, and compared the results against computational predictions of where they bind.

B.S. Biomedical Engineering (with honors)

Georgia Institute of Technology

2008–2012
Focus
Human-centered clinical systems.
Capstone
A diabetes management portal with real-time feedback and clinical decision support — the first system I built that made recommendations to patients from their own data.
Honors
BME Outstanding Leader of the Year, 2012. Rebuilt the Biomedical Engineering Society from dormant to 250 members.

MBA

NYU Stern School of Business

2019
Focus
Finance and technology: the parts of a company I had built around without studying.
Path
I had an MD admission, deferred it a year to try healthcare technology at Epic, and turned it down at the end of that year. Business school came out of that decision.

Co-Founder and Organizer

BREAD

2015–present

Co-founded a not-for-profit event series and art collective to bring attention to local talent and give marginalized cultural groups a stage. Produced 27 events across 18 venues between 2015 and 2024 with a team of four, ran a weekly radio show, and booked talent for SF clubs: bookings, budgets, venues, and night-of logistics.

Agent Authorization SystemsAI Deployment ReadinessClinical Workflow RoutingEHR Integration SystemsEvidence VerificationAudit Trail Design

Revised